Title A motif in LILRB2 critical for Angptl2 binding and activation
Authors Deng, Mi
Lu, Zhigang
Zheng, Junke
Wan, Xuan
Chen, Xiaoli
Hirayasu, Kouyuki
Sun, Hanzi
Lam, Yeeling
Chen, Liping
Wang, Qihui
Song, Chun
Huang, Niu
Gao, George F.
Jiang, Youxing
Arase, Hisashi
Zhang, Cheng Cheng
Affiliation Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.
Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Lab Chem Genom, Shenzhen, Peoples R China.
Shanghai Jiao Tong Univ, Sch Med, Dept Pathophysiol,Shanghai Univ Inst Chem Biol E, Key Lab Cell Differentiat & Apoptosis Chinese,Min, Shanghai 200030, Peoples R China.
Osaka Univ, Microbial Dis Res Inst, Dept Immunochem, Osaka, Japan.
Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Lab Immunochem, Osaka, Japan.
Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Osaka, Japan.
Natl Inst Biol Sci, Beijing, Peoples R China.
Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
Shandong Univ, Jinan 250100, Peoples R China.
Natl New Drug R&D Ctr Shandong, Jinan, Peoples R China.
Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.
Chongqing South Rd 280, Shanghai 200025, Peoples R China.
Keywords HEMATOPOIETIC STEM-CELLS
EX-VIVO EXPANSION
UMBILICAL-CORD BLOOD
PROGENITOR CELLS
SELF-RENEWAL
HLA-G
TRANSPLANTATION
PROTEINS
RECEPTORS
RECOGNITION
Issue Date 2014
Publisher blood
Citation BLOOD.2014,124,(6),924-935.
Abstract A better understanding of the interaction between extrinsic factors and surface receptors on stem cells will greatly benefit stem cell research and applications. Recently, we showed that several angiopoietin-like proteins (Angptls) bind and activate the immune inhibitory receptor human leukocyte immunoglobulin(Ig)-like receptor B2(LILRB2) to support ex vivo expansion of hematopoietic stem cells (HSCs) and leukemia development. However, the molecular basis for the interaction between Angptls and LILRB2 was unclear. Here, we demonstrate that Angptl2 expressed in mammalian cells forms high-molecular-weight species and that lig and multimerization is required for activation of LILRB2 for downstream signaling. A novel motif in the first and fourth Ig domains of LILRB2 was identified that is necessary for the receptor to be bound and activated by Angptl2. The binding of Angptl2 to LILRB2 is more potent than and not completely overlapped with the binding of another ligand, HLA-G. Immobilized anti-LILRB2 antibodies induce a more potent activation of LILRB2 than Angptl2, and we developed a serum-free culture containing defined cytokines and immobilized anti-LILRB2 that supports a net expansion of repopulating human cord blood HSCs. Our elucidation of the mode of Angptl binding to LILRB2 enabled the development of a new approach for ex vivo expansion of human HSCs.
URI http://hdl.handle.net/20.500.11897/342150
ISSN 0006-4971
DOI 10.1182/blood-2014-01-549162
Indexed SCI(E)
PubMed
Appears in Collections: 化学生物学与生物技术学院

Files in This Work
There are no files associated with this item.

Web of Science®


56

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.